Yale School of Medicine (YSM) reports that in collaboration with Yale New Haven Hospital (YNHH), it will be participating in the National Institutes of Health (NIH) Maternal-Fetal Medicine Units (MFMU) Network.
Established in 1986, MFMU was founded to conduct clinical trials in such areas as reducing rates of preterm birth, fetal growth abnormalities, newborn morbidity, and maternal complications of pregnancy.
MFMU was established by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Initially consisting of seven clinical centers and a coordinating data center participating in common protocols to conduct clinical trials, it now comprises a network of investigators that have conducted 54 studies, 530 presentations and 325 peer-reviewed manuscripts published in leading journals. The network also comprises 12 university-based clinical centers and a coordinating data center.
MFMU advanced practice such as the use of late-term steroids to reduce the risk of respiratory problems in newborns and the finding that induction of labor at 39 weeks leads to similar or better outcomes compared to expectant management. Two key areas of MFMU focus presently is addressing two of the most important problems in maternal-fetal medicine: preterm birth and obstetric hemorrhage.
Yale’s Christian Pettker, MD, associate professor of obstetrics, gynecology and reproductive sciences at YSM noted, “Yale New Haven Hospital has become nationally known for high-quality clinical care” and by “joining MFMU puts us at the forefront of obstetrics research that has the potential to lead to better pregnancy outcomes and healthier newborns.”
Nationwide there are 165,000 deliveries in the MFMU of which Yale New Haven Hospital will contribute 6,000 per year.